Press Releases

The National Heart, Lung, and Blood Institute, one of the institutes that make up the National Institutes of Health, has awarded $347,608 to Biotherapeutics, Inc., located in Blacksburg, Virginia, for lung disease research as it relates to asthma. According to the American Lung Association, more than twenty-five million Americans live with asthma. Of those affected, somewhere between one and two million people suffer from severe asthma. U.S. Congressman Morgan Griffith (R-VA) issued the following statement:

“Our understanding and research of asthma therapeutics continues to grow.

“This grant for nearly $350,000 helps Biotherapeutics study and assess the next wave of asthma therapeutics.”

BACKGROUND

This funding is supported by the Small Business Innovation Research (SBIR) grants program. Goals of the program include stimulating technological innovation, using small business to meet Federal research and development needs, and promoting private sector commercialization of innovations.

In August and September of 2024, Congressman Griffith announced that Biotherapeutics, Inc. received multiple grants for a sum total of more than $640,000.

###